Onuoha Kemjika O, Solow Max, Newman Jared M, Sodhi Nipun, Pivec Robert, Khlopas Anton, Sultan Assem A, Chughtai Morad, Shah Neil V, George Jaiben, Mont Michael A
Department of Orthopaedic Surgery, SUNY Downstate Medical Center Brooklyn, New York, USA.
St. Georges University School of Medicine, St. George's, West Indies, Grenada.
Ann Transl Med. 2017 Dec;5(Suppl 3):S35. doi: 10.21037/atm.2017.11.15.
Rheumatoid arthritis (RA) is characterized by chronic systemic and synovial inflammation, resulting in damage to both cartilage and bone. Medical treatment, which has increasingly relied upon disease modifying anti-rheumatic drugs (DMARDs), may fail to slow disease progression and limit joint damage, ultimately warranting surgical intervention. Up to 25% of RA patients will require lower extremity total joint arthroplasty. Though total hip arthroplasty (THA) is known to improve quality of life and functional measures, clarification is still required with respect to the impact of increased DMARD use on annual rates of THA. Thus, the purpose of this study was to evaluate: (I) the annual trends of THAs due to RA in the United States population; (II) the annual trends in the proportion of THAs due to RA in the United States.
This study utilized the Nationwide Inpatient Sample (NIS) to identify all patients who underwent THA between 2002 and 2013 (n=3,135,904). Then, THA patients who had a diagnosis of RA, which was defined by the International Classification of Disease 9 revision diagnosis code 714.0, were identified. The incidence of THAs with a diagnosis of RA in the United States was calculated using the United States population as the denominator. Regression models were used to analyze the annual trends of RA in patients who underwent THA.
Review of the database identified 90,487 patients who had a diagnosis of RA and underwent THA from 2002 to 2013. The annual prevalence of RA in those who underwent THA slightly decreased over the specified time period, with 28.7 per 1,000 THAs in 2002 and 28.6 per 1,000 THAs in 2013; however, this change was not statistically significant (R=0.158, P=0.200).
The annual rates of THA among RA patients did not show any significant change between 2002 and 2013. DMARD use has decreased both disease progression and joint destruction, and DMARDs are now often utilized as primary treatment. The increase in population of the country during the study period may have overestimated THA trends. Moreover, patients may be more likely to opt for surgical management, given the advances in operative techniques as well as peri- and post-operative course.
类风湿性关节炎(RA)的特点是慢性全身性和滑膜炎症,会导致软骨和骨骼受损。越来越依赖改善病情抗风湿药(DMARDs)的药物治疗可能无法减缓疾病进展并限制关节损伤,最终需要进行手术干预。高达25%的RA患者需要进行下肢全关节置换术。虽然全髋关节置换术(THA)已知可改善生活质量和功能指标,但关于增加DMARDs使用对THA年发生率的影响仍需进一步明确。因此,本研究的目的是评估:(I)美国人群中因RA进行THA的年度趋势;(II)美国因RA进行THA的比例的年度趋势。
本研究利用全国住院患者样本(NIS)来识别2002年至2013年期间接受THA的所有患者(n = 3,135,904)。然后,识别出诊断为RA的THA患者,RA由国际疾病分类第9版诊断代码714.0定义。以美国人口为分母计算美国诊断为RA的THA的发病率。使用回归模型分析接受THA的患者中RA的年度趋势。
对数据库的审查确定了90,487名在2002年至2013年期间诊断为RA并接受THA的患者。在指定时间段内,接受THA的患者中RA的年患病率略有下降,2002年每1000例THA中有28.7例,2013年每1000例THA中有28.6例;然而,这种变化无统计学意义(R = 0.158,P = 0.200)。
2002年至2013年期间,RA患者的THA年发生率没有显示出任何显著变化。DMARDs的使用减少了疾病进展和关节破坏,并且DMARDs现在经常被用作主要治疗方法。研究期间该国人口的增加可能高估了THA趋势。此外,鉴于手术技术以及围手术期和术后过程的进步,患者可能更倾向于选择手术治疗。